Prestigious award seeks to advance new avenue of addiction treatment

Chemical biologist is one of only two OHSU scientists ever to earn Avenir Award; project targets cannabinoid receptors for opioid treatment

Dr James Frank in his lab
James Frank, Ph.D., will use new Avenir Award funding from NIDA to investigate cannabinoid receptors as an alternative toward treatment for opioid use disorder. (OHSU/Christine Torres Hicks)

A chemical biologist at Oregon Health & Science University has become just the second researcher in the institution’s history to receive a prestigious Avenir Award from the National Institute on Drug Abuse, known as NIDA, of the National Institutes of Health.

James Frank, Ph.D., assistant professor of chemical physiology and biochemistry in the OHSU School of Medicine and the Vollum Institute at OHSU, will use the award to develop new tools to improve understanding of an alternative suite of receptors in the brain believed to be involved in opioid addiction.

Read the full article
Frank Lab